Answers are grounded in this paper and cite their sources.
: According to the results of the present investigations, 10-HDA at the doses of 2.5 and 5 mg/kg especially in combination with CP showed promising antitumor effects against EST in mice and can be recommended as a new or alternative anticancer agent against tumor; nevertheless, further investigations, particularly in clinical setting, are required to confirm these results.
No takes yet. Share an insight, caveat, or question.
Albalawi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: